Elena Cichero

University of Genoa — Italy

Biochemistry, Genetics and Molecular Biology · Life Sciences

25h-index1.8kcitations114works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Receptor Mechanisms and Signaling(32), Pharmacological Receptor Mechanisms and Effects(19), Cystic Fibrosis Research Advances(17), Neurotransmitter Receptor Influence on Behavior(15), Computational Drug Discovery Methods(15)

Publications114 total

USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and Tumorigenesis
Molecules·2025Open Access
Immunoregulatory properties of cell free DNA
Cellular and Molecular Life Sciences·2025· 1 citedOpen Access
Alzheimer’s Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective
International Journal of Molecular Sciences·2025· 7 citedOpen Access
Structure-guided combination of novel CFTR correctors to improve the function of F508del-CFTR in airway epithelial cells
Biochemical Pharmacology·2025Open Access
Triazole-imidazo[1,2-b]pyrazoles Able to Counteract Melanoma Cell Survival Without Compromising the Viability of Healthy Keratinocytes
International Journal of Molecular Sciences·2025· 1 citedOpen Access
Discovery of Novel Thiazole-Based SIRT2 Inhibitors as Anticancer Agents: Molecular Modeling, Chemical Synthesis and Biological Assays
International Journal of Molecular Sciences·2024· 1 citedOpen Access
Computational Methods for the Discovery and Optimization of TAAR1 and TAAR5 Ligands
International Journal of Molecular Sciences·2024· 1 citedOpen Access
Recent Advances in the Discovery of SIRT1/2 Inhibitors via Computational Methods: A Perspective
Pharmaceuticals·2024· 8 citedOpen Access
Discovery of a Novel Chemo-Type for TAAR1 Agonism via Molecular Modeling
Molecules·2024· 6 citedOpen Access
New Pyrazolyl Thioureas Active against the Staphylococcus Genus
Pharmaceuticals·2024· 2 citedOpen Access
Meet the Editorial Board Member
Current Medicinal Chemistry·2024
Cyclic diacyl thioureas enhance activity of corrector Lumacaftor on F508del‐CFTR
ChemMedChem·2023· 4 citedOpen Access
New Insights into the LANCL2-ABA Binding Mode towards the Evaluation of New LANCL Agonists
Pharmaceutics·2023· 5 citedOpen Access
In Silico and In Vitro Evaluation of the Mechanism of Action of Three VX809-Based Hybrid Derivatives as Correctors of the F508del CFTR Protein
Pharmaceuticals·2023· 4 citedOpen Access
Discovery of Guanfacine as a Novel TAAR1 Agonist: A Combination Strategy through Molecular Modeling Studies and Biological Assays
Pharmaceuticals·2023· 6 citedOpen Access
Novel Thiazole-Based SIRT2 Inhibitors Discovered via Molecular Modelling Studies and Enzymatic Assays
Pharmaceuticals·2023· 14 citedOpen Access
SIRT6 pharmacological inhibition delays skin cancer progression in the squamous cell carcinoma
Biomedicine & Pharmacotherapy·2023· 11 citedOpen Access
Virtual Screening Combined with Enzymatic Assays to Guide the Discovery of Novel SIRT2 Inhibitors
International Journal of Molecular Sciences·2023· 7 citedOpen Access
Novel thienocycloalkylpyridazinones as useful scaffolds for acetylcholinesterase inhibition and serotonin 5-HT6 receptor interaction
Bioorganic & Medicinal Chemistry·2023· 8 citedOpen Access
Scouting Different Phosphodiesterase 4 Inhibitor Chemotypes in Silico To Guide the Design of Anti‐inflammatory/Antioxidant Agents
ChemMedChem·2023· 2 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Paola Fossa(37), Michele Tonelli(14), Raul R. Gainetdinov(9), Stefano Espinoza(8), Livio Brasili(8), Silvia Franchini(7), Sara Guariento(5), Enrico Millo(5), Olga Bruno(5), Luisa Mosti(5), Valeria Francesconi(4), Antonio Cilia(4), Pasqualina D’Ursi(4), Luciano Milanesi(4), Andrea Spallarossa(4), Claudia Sorbi(4), Sara Cesarini(4), Lieve Naesens(3), Adolfo Prandi(3), Lorenza Pirona(3)